T Bill Cai, Dongning Lu, Peng George Wang
Index: Curr. Top. Med. Chem 5(7) , 721-36, (2005)
Full Text: HTML
Nitric oxide (NO) has been implicated in a wide variety of disease states. Both inhibitors and substrates of nitric oxide synthase (NOS) could have great therapeutic potential in the treatment of these diseases. There is considerable pharmacological interest in developing inhibitors of NOS, and hundreds of inhibitors have been identified. In contrast, the study on NOS substrates is less active. The advances in the identification, design and development of NOS substrates are discussed in this review. The focus is the chemistry and biochemistry of N-hydroxyguanidines. The crystal structures of substrates bound to NOSs and the mechanisms of NOS catalyzed NO generation from substrates are also discussed.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Hydroxyguanidine Sulfate
CAS:6345-29-5 |
C2H12N6O6S |
|
A new class of NO-donor pro-drugs triggered by γ-glutamyl tr...
2013-02-18 [Chem. Commun. (Camb.) 49(14) , 1389-91, (2013)] |
|
Microsomal formation of nitric oxide and cyanamides from non...
1999-08-01 [Biochem. Pharmacol. 58(3) , 439-45, (1999)] |
|
Unusual oxidative chemistry of N(omega)-hydroxyarginine and ...
2000-03-24 [J. Biol. Chem. 275(12) , 8582-91, (2000)] |
|
1-(2-Mercaptobenzenesulfonyl)-3-hydroxyguanidines--novel pot...
2012-09-01 [Eur. J. Med. Chem. 55 , 384-94, (2012)] |
|
Efficient formation of nitric oxide from selective oxidation...
1999-04-13 [Biochemistry 38(15) , 4663-8, (1999)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
